Fate Therapeutics (FATE) Receivables - Accured (2019 - 2026)
Fate Therapeutics' Receivables - Accured came in at $300,000 for Q2 2026, down 85.0% from $2 million a year earlier and down 62.5% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Receivables - Accured (2019 - 2026) Analysis & Trends
At the end of FY2025, Fate Therapeutics' Receivables - Accured was $700,000, down 66.7% from FY2024.
- Receivables - Accured carries a five-year compound annual growth rate of -14.1% (FY2020 to FY2025).
- Going back by year, Receivables - Accured was $2.1 million in FY2024 (+133.3%), $900,000 in FY2023 (+12.5%), $800,000 in FY2022 (-27.3%) and $1.1 million in FY2021 (-26.7%).
- The Q2 2026 figure represents the lowest quarterly Receivables - Accured since Q2 2023.
- Year-over-year, Receivables - Accured has declined for four consecutive quarters, with growth averaging 15.7% over the last eight quarters.
- The fastest year-over-year change in Receivables - Accured over five years came in Q4 2024 (growth of 133.3%), and the weakest in Q2 2022 (a decline of 100.0%).
- Business Quant data shows FATE's Receivables - Accured at $800,000 (Q1 2026), $700,000 (Q4 2025) and $1.4 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Fate Therapeutics | 277.73 Mn | 277.73 Mn | - | 300,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 300,000.00 |
| Mar 31, 2026 | 800,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 900,000.00 |
| Dec 31, 2023 | 900,000.00 |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 1,100.00 |
| Mar 31, 2023 | 900,000.00 |
| Dec 31, 2022 | 800,000.00 |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 1.40 Mn |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 1.70 Mn |
API Access
Fate Therapeutics Receivables - Accured API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-accured&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-accured", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-accured&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();